Signal active
Organization
Contact Information
Overview
IMU is a discovery engine mapping the immune system to advance precision medicine.
About
Biotechnology, Life Science, Health Care, Precision Medicine
2021
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
IMU Biosciences headquartered in Europe, operates in the Biotechnology, Life Science, Health Care, Precision Medicine sector. The company focuses on Biotechnology and has secured $468.0M in funding across 32 round(s). With a team of 11-50 employees, IMU Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - IMU Biosciences, raised $14.6M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
2
2
0
$14.6M
Details
1
IMU Biosciences has raised a total of $14.6M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2024 | Early Stage Venture | 14.6M |
Investors
IMU Biosciences is funded by 7 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
IMU Biosciences | - | FUNDING ROUND - IMU Biosciences | 14.6M |
Molten Ventures | - | FUNDING ROUND - Molten Ventures | 14.6M |
IMU Biosciences | - | FUNDING ROUND - IMU Biosciences | 14.6M |
Life Extension Ventures | - | FUNDING ROUND - Life Extension Ventures | 14.6M |
Recent Activity
There is no recent news or activity for this profile.